Gauzy plans Nasdaq appeal after delisting notice on $1 bid-price breach
Bitget2026/09/21 20:30- Gauzy received a Nasdaq delisting notice dated Sept. 15, 2026, targeting its securities for removal from the Nasdaq Global Market.
- Nasdaq cited the ordinary shares trading below $1 for 30 straight business days, with the company failing to regain compliance by Sept. 14, 2026.
- Delisting also tied to failure to file its Form 20-F for the year ended Dec. 31, 2025.
- Gauzy plans to appeal via an oral hearing request by Sept. 22, 2026, which would keep the shares trading pending the hearing.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024
siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).
Crypto prices
More
